ClinicalTrials.gov
public full text
Public Domain
Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy
An observational study tracking the clinical course of patients with IgA nephropathy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy#387258
- Mediators of Loin Pain in IgA Nephropathy#852002
- A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN#911473
- A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy#1058799
- Registry of IgA Nephropathy in Chinese Children#1150022
Record · ID 855538
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive